Short Michigan Alcoholism Screening Test (SMAST)
13-item brief version of the MAST for alcohol use disorder screening. Score ≥3 = probable alcoholism. Score 1–2 = possible; score 0 = unlikely. Validated in multiple settings.
Score interpretation
SMAST 0 — alcoholism unlikely
→ Brief preventive advice; reassess if clinical concerns arise
SMAST 1–2 — possible alcohol use disorder
→ Brief motivational interview; AUDIT questionnaire for severity; psychoeducation on safe drinking limits; follow-up in 4–6 weeks; consider referral to community alcohol team
SMAST ≥3 — probable alcohol use disorder
→ Formal alcohol use disorder diagnosis; alcohol withdrawal risk assessment (CIWA-Ar/GMAWS); refer to addiction services; offer pharmacotherapy (acamprosate, naltrexone, disulfiram); AUDIT-C; liver function tests; thiamine supplementation
Interpretation bands for the SMAST. Apply clinical judgement and local guidance.
References
- Selzer ML, Vinokur A, van Rooijen L. A self-administered Short Michigan Alcoholism Screening Test (SMAST). J Stud Alcohol. 1975;36(1):117–126.
Related
Curated clinical cross-links plus same-class fallbacks.
- Tetracosactide · Synthetic ACTH (short Synacthen test)
- Remifentanil · Opioid (Ultra-Short-Acting)
- Alfentanil · Opioid Analgesic (Ultra-Short Acting)
- Fentanyl (IV — Anaesthesia/ICU) · Opioid Analgesic (Short-Acting)
- Remimazolam · Ultra-Short Acting Benzodiazepine (Procedural Sedation)
- Chloroprocaine hydrochloride · Short-acting ester local anaesthetic
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.